Differentiation of microfluidic‐encapsulated trabecular meshwork mesenchymal stem cells into insulin producing cells and their impact on diabetic rats
- 14 October 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (5) , 6801-6809
Abstract
Tissue and stem cell encapsulation andtransplantation were considered as promising tools in the treatment of patients with diabetes mellitus. The aim of this study was to evaluate the effect of microfluidic encapsulation on the differentiation of trabecular meshwork mesenchymal stem cells (TM‐MSC), into insulin‐producing cells (IPCs) both in vitro and in vivo. The presence of differentiated cells in microfibers (three dimensional [3D]) and tissue culture plates (TCPS; two dimensional [2D]) culture was evaluated by detecting mRNA and protein expression of pancreatic islet‐specific markers as well as measuring insulin release of cells in response to glucose challenges. Finally, semi‐differentiated cells in microfibers (3D) and 2D cultures were used to control the glucose level in diabetic rats. The results of this study showed that MSCs differentiated in alginate microfibers (fabricated by microfluidic device) express more Pdx‐1 mRNA (1.938‐fold, p‐value: 0.0425) and Insulin mRNA (2.841‐fold, p‐value: 0.0001) compared with those cultured on TCPS. Furthermore, cell encapsulation in microfluidic derived microfibers decreased the level of blood glucose in diabetic rats. The approach used in this study showed the possibility of alginate microfibers as a matrix for differentiation of TM‐MSCs (as a new source) into IPCs. In addition, it could minimize different steps in stem cell differentiation, handling, and encapsulation, which lead to loss of an unlimited number of cells.Keywords
Funding Information
- Zanjan University of Medical Sciences (A‐10‐892‐5)
This publication has 53 references indexed in Scilit:
- Matrix Components and Scaffolds for Sustained Islet FunctionTissue Engineering Part B: Reviews, 2011
- Co-encapsulation of bioengineered IGF-II-producing cells and pancreatic islets: effect on beta-cell survivalGene Therapy, 2011
- Novel PDMS cylindrical channels that generate coaxial flow, and application to fabrication of microfibers and particlesLab on a Chip, 2010
- Stem Cells to Pancreatic β-Cells: New Sources for Diabetes Cell TherapyEndocrine Reviews, 2009
- Cell Therapy for Diabetes Mellitus: An Opportunity for Stem Cells?Cells Tissues Organs, 2008
- Control of hepatic differentiation via cellular aggregation in an alginate microenvironmentBiotechnology and Bioengineering, 2007
- Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cellsNature Biotechnology, 2006
- Biocompatibility and function of microencapsulated pancreatic isletsActa Biomaterialia, 2006
- Alginate‐PLL microencapsulation: Effect on the differentiation of embryonic stem cells into hepatocytesBiotechnology and Bioengineering, 2006
- Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2Nature Genetics, 1997